EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Relationship between melanogenesis, proliferative activity and response to chemotherapy of human melanoma xenografts






Neoplasma 31(5): 545-549

Relationship between melanogenesis, proliferative activity and response to chemotherapy of human melanoma xenografts

A wide range of different drugs used in the cytotoxicity studies in an amelanotic human melanoma [HX/47 cells] xenograft on nude mice showed a clear inverse relationship between melanogenesis and proliferation. Decreasing rates in proliferative activity estimated by mitotic activity expressed by phase distribution changes as well as by the tumor volume response to drug treatment were in direct relationship with increasing rates in the degree of melanogenesis expressed in percentage of melanin containing cells in histological specimens.

(PDF 0-2 workdays service: $29.90)

Accession: 006297611

PMID: 6504213



Related references

Genotyping of NAD Hquinone oxidoreductase in a panel of human tumor xenografts Relationship between genotype status, NQO1 activity and the response of xenografts to Mitomycin C chemotherapy in vivo. Biochemical Pharmacology 62(10): 1371-1377, 15 November, 2001

Genotyping of NAD(P)H:quinone oxidoreductase (NQO1) in a panel of human tumor xenografts: Relationship between genotype status, NQO1 activity and the response of xenografts to Mitomycin C chemotherapy in vivo. Biochemical Pharmacology 62(10): 1371-1377, 2001

Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice. International Journal of Cancer 25(4): 453-458, 1980

An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs. British Journal of Cancer 41(5): 829-831, 1980

Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts. Cancer ChemoTherapy and Pharmacology 51(3): 247-255, 2003

MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma. Melanoma Research 2(1): 5-12, 1992

Local tumor control following single dose irradiation of human melanoma xenografts: relationship to cellular radiosensitivity and influence of an immune response by the athymic mouse. Cancer Research 49(12): 3163-3167, 1989

Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells. Melanoma Research 2(5-6): 305-314, 1992

Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. British Journal of Cancer 42(3): 438-447, 1980

Establishment of a melanogenesis regulation assay system using a fluorescent protein reporter combined with the promoters for the melanogenesis-related genes in human melanoma cells. Enzyme and Microbial Technology 68: 1-9, 2015